Event date: 02-03-2023
Event Time: 12:00 PM
Venue:Mintz Levin, One Financial Center, Boston, MA 02111
* US-Israel Funding Opportunities
You are cordially invited to meet BIRD’s new Executive Director, Mr. Jaron Lotan and Dr. Eitan Yudilevich, BIRD’s outgoing Executive Director, retiring after 17 years of leadership.
This is a great opportunity to learn about BIRD Foundation funding opportunities for joint R&D cooperation between U.S. and Israeli companies and hear from BIRD current and past winners.
BIRD is an acronym for Israel-U.S. Binational Industrial Research and Development. The BIRD Foundation’s mission is to stimulate, promote and support industrial R&D of mutual benefit to the U.S. and Israel.
The BIRD Foundation was established by the U.S. and Israeli governments in 1977 to generate mutually beneficial cooperation between U.S. and Israeli companies, including start-ups and established organizations. BIRD provides funding up to $1.5M per project and matchmaking support between U.S. and Israeli companies, BIRD takes no equity in the companies.
BIRD supports approximately 20 projects annually. The cumulative sales of products developed through BIRD projects have exceeded $10 billion.
Since its inception, BIRD has approved over 1000 projects, including over 100 projects in Massachusetts, with leading companies in the U.S. and Israel. To name few of them: ADM, American Red Cross, Applied Materials, Avaya, Bayer Pharmaceutical, Becton Dickinson, Bio-Rad Laboratories, General Dynamics, General Electric, IBM, J&J, Motorola, Procter & Gamble, Beth Israel Lahey Health, Telcordia, Texas Instruments, Netafim, GE Health, Thermo Fisher, Karyopharm, Spaulding Rehabilitation Network, UMASS medical School and more.
To learn more about BIRD funding and recent winners: http://www.birdf.com/